World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—
Khiron Life Sciences in brief
Khiron Life Sciences is a listed company in the Pharmaceutical industry, based in Canada. Its last known market value was $32 M (January 2022); there is no current figure. Its shares trade under the symbol KHRN.V (TSX Venture).
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
Market cap history
World rank over time
▼ down 9,721 places since 2020
Rank in Canada: #518 (Jan 2020) · #573 (Jan 2021) · #1,140 (Jan 2022)
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Khiron Life Sciences🇨🇦 | $32 M | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- Merck & Co., Inc.$359.8 B
- Novartis AG$286.8 B
How current the figures are
- Market cap:
- Jan 7, 2022 (last known)
- Profile updated:
- Nov 15, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Khiron Life Sciences? Verify and update this profile — free
Show Khiron Life Sciences's ranking on your website Get the badge
The badge updates itself as the ranking changes.